We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company is sponsoring clinical research on the system in three study programs worldwide, including an early feasibility study in the U.S. Read More
The test can detect different genes from the SARS-CoV-2 virus that causes COVID-19 infection, making it more robust in detecting emerging viral variants, including Omicron. Read More